Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


03.09.2018

2 Am J Hematol
2 Ann Hematol
1 Blood
1 BMC Genomics
2 Cancer Res
4 Int J Hematol
3 Leuk Lymphoma
1 Leuk Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. YANG MH, Wan WQ, Luo JS, Zheng MC, et al
    Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: interim results of the SCCLG-APL clinical study.
    Am J Hematol. 2018 Aug 30. doi: 10.1002/ajh.25271.
    PubMed     Text format     Abstract available

  2. JAIN P, Kanagal-Shamanna R, Konoplev SN, Zuo Z, et al
    Biclonal IGHV-4-34 variant hairy cell leukemia and CLL - successful treatment with ibrutinib and venetoclax.
    Am J Hematol. 2018 Aug 28. doi: 10.1002/ajh.25264.
    PubMed     Text format    


    Ann Hematol

  3. TIMMERS NKLM, de Maar JS, van Kruijsdijk RCM, Klein SK, et al
    Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature.
    Ann Hematol. 2018;97:1627-1632.
    PubMed     Text format     Abstract available

  4. HATTA Y, Mizuta S, Matsuo K, Ohtake S, et al
    Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
    Ann Hematol. 2018;97:1535-1545.
    PubMed     Text format     Abstract available


    Blood

  5. ALSADEQ A, Lenk L, Vadakumchery A, Cousins A, et al
    IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
    Blood. 2018 Aug 28. pii: blood-2018-04-844209. doi: 10.1182/blood-2018-04-844209
    PubMed     Text format    


    BMC Genomics

  6. OLUWADARE O, Zhang Y, Cheng J
    A maximum likelihood algorithm for reconstructing 3D structures of human chromosomes from chromosomal contact data.
    BMC Genomics. 2018;19:161.
    PubMed     Text format     Abstract available


    Cancer Res

  7. INSELMANN S, Wang Y, Saussele S, Fritz L, et al
    Development, function and clinical significance of plasmacytoid dendritic cells in chronic myeloid leukemia.
    Cancer Res. 2018 Aug 30. pii: 0008-5472.CAN-18-1477.
    PubMed     Text format     Abstract available

  8. MINIERI V, De Dominici M, Porazzi P, Mariani SA, et al
    Targeting STAT5 or STAT5-regulated pathways suppresses leukemogenesis of Ph+ acute lymphoblastic leukemia.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0195.
    PubMed     Text format     Abstract available


    Int J Hematol

  9. TAN TK, Zhang C, Sanda T
    Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
    Int J Hematol. 2018 Aug 25. pii: 10.1007/s12185-018-2518.
    PubMed     Text format     Abstract available

  10. WATANABE N, Takaku T, Takeda K, Shirane S, et al
    Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients.
    Int J Hematol. 2018 Aug 27. pii: 10.1007/s12185-018-2517.
    PubMed     Text format     Abstract available

  11. INOUE A, Kobayashi CI, Shinohara H, Miyamoto K, et al
    Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistence.
    Int J Hematol. 2018 Aug 28. pii: 10.1007/s12185-018-2519.
    PubMed     Text format     Abstract available

  12. MINAMI Y
    Guest editorial: chronic myeloid leukemia.
    Int J Hematol. 2018 Aug 28. pii: 10.1007/s12185-018-2521.
    PubMed     Text format    


    Leuk Lymphoma

  13. BORLENGHI E, Cattaneo C, Schieppati F, Gramegna D, et al
    Acute promyelocytic leukemia in patients aged >70 years is not rare and highly curable: a single center series of 21 unselected patients.
    Leuk Lymphoma. 2018 Aug 30:1-4. doi: 10.1080/10428194.2018.1492126.
    PubMed     Text format    

  14. CAO M, Carrasco RD, Dubuc AM, Dal Cin P, et al
    ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia.
    Leuk Lymphoma. 2018 Aug 30:1-3. doi: 10.1080/10428194.2018.1493733.
    PubMed     Text format    

  15. SPEZIALI C, Daly A, Abuhaleeqa M, Nitta J, et al
    Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
    Leuk Lymphoma. 2018 Aug 30:1-10. doi: 10.1080/10428194.2018.1493734.
    PubMed     Text format     Abstract available


    Leuk Res

  16. MANUKYAN G, Turcsanyi P, Mikulkova Z, Gabcova G, et al
    Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
    Leuk Res. 2018;72:113-119.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: